| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 142.80 | 19.88 | 22.77p | 54.0 | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 139.99 | (45.98) | (41.29)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 89.54 | (188.53) | (163.11)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 128.80 | (47.27) | (41.75)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-25 | 168.74 | (31.94) | (26.92)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Deutsche Bank downgrades Oxford Biomedica after ... | 18-Aug-2026 |
| Oxford Biomedica shares tank after FY sales, mar... | 07-Aug-2026 |
| Oxford Biomedica inks service deal with Plowshar... | 16-Jul-2026 |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Price | 424.00p |
| Change Today | -23.00p |
| 52 Week High | 913.00p |
| 52 Week Low | 424.00p |
| Volume | 2,403,365 |
| Shares Issued | 121.05m |
| Market Cap | £513.25m |